Trial Profile

First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 27 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs UP 421 (Primary)
Indications Type 1 diabetes mellitus
Focus Adverse reactions; First in man
Sponsors Sana Biotechnology

Most Recent Events

23 Jun 2025 According to a Sana Biotechnology media release, data Shared at Presentation at the 85th Annual American Diabetes Association (ADA) Scientific Sessions.
23 Jun 2025 According to a Sana Biotechnology media release, study results submitted for publication in a peer-reviewed journal.
23 Jun 2025 Results presented in the Sana Biotechnology Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com